Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

46

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

46 results for “Astaxanthin”

Learn how ShareScore rates datasets ↗
zenodo36/100

Metadata - Astaxanthin has a beneficial influence on pain-related symptoms and opioid-induced hyperalgesia in mice with diabetic neuropathy-evidence from behavioral studies

Open the record for dataset details and reuse information.

opencc-by-4.0Nov 2024View details →
dryad36/100

Astaxanthin from Haematococcus pluvialis prevents high-fat diet-induced hepatic steatosis and oxidative stress in mice by gut-liver axis modulating properties

<p><strong><span>Scope:</span></strong><span> Evidence is mounting that astaxanthin (ATX), a xanthophyll carotenoid, used as a nutritional supplement to prevent chronic metabolic diseases. The present study aims to identify the potential function of ATX supplementation in preventing steatohepatitis and hepatic oxidative stress in diet-induced obese mice.</span></p> <p><strong><span>Methods and Results:</span></strong><span> In this study, ATX as dose of 0.25%, 0.5% and 0.75% have orally administered to mice along with a high-fat diet (HFD) to investigate the role of ATX in regulating liver lipid metabolism and gut microbiota. The study showed that ATX dose-dependently reduces body weight, lipid droplet formation, hepatic triglycerides and ameliorated hepatic steatosis and oxidative stress. 0.75% ATX altered the levels of 34 lipid metabolites related to hepatic cholesterol and fatty acid metabolism which might be associated with downregulation of lipogenesis-related genes and upregulation of bile acid biosynthesis-related genes. The result also revealed that ATX alleviates HFD-induced gut microbiota dysbiosis by significantly inhibiting the growth of obesity-related <em>Parabacteroides</em> and <em>Desulfovibrio</em> while promoting the growth of <em>Allobaculum</em> and <em>Akkermansia</em>. </span></p> <p><span><strong>Conclusion:</strong> The study results suggested that dietary ATX may prevent the development of hepatic steatosis and oxidative stress with the risk of metabolic disease by gut-liver axis modulating properties.</span></p>

opencc-zeroApr 2022View details →
dryad36/100

Data from: Optimization and characterization of PLGA nanoparticles loaded with Astaxanthin and evaluation of anti-photodamage effect in vitro

<p><span><span>Astaxanthin is a xanthophyll carotenoid with </span><span>high</span><span> beneficial biological activities, such as antioxidant function and scavenging oxygen free radicals, but its application is limited because of poor water solubility and low bioavailability. Here, we prepared and optimized poly (lactic-co-glycolic acid) (PLGA) nanoparticles loaded with astaxanthin using the emulsion solvent evaporation technique and investigated the anti-photodamage effect in Ha</span><span>C</span><span>a</span><span>T</span><span> cells. The four-factor three-stage Box-Behnken design was used to optimize the nanoparticle formulation. The experimental determination of the optimal nanoparticle size was 154.4 ± 0.35 nm, the zeta potential was 22.07 ± 0.93 mV, encapsulation efficiency was 96.42 ± 0.73%, and drug loading capacity was 7.19 ± 0.12%. The physicochemical properties of the optimized nanoparticles were characterized by dynamic light scattering, SEM, TEM, FTIR, XRD, DSC, and TGA. <i>In vitro</i> study exhibited the excellent cell viability and cellular uptake of optimized nanoparticle on Ha</span><span>C</span><span>a</span><span>T</span><span> cells. The anti-photodamage studies (cytotoxicity assay, ROS content, and JC-1 assessment) demonstrated that the optimized nanoparticles were more effective and safer than pure astaxanthin in Ha</span><span>C</span><span>a</span><span>T</span><span> cells. These results suggest that our PLGA-coated astaxanthin nanoparticles synthesis method was highly feasible, and can be used in cosmetics or the treatment of skin diseases.</span></span></p>

opencc-zeroOct 2019View details →
ClinicalTrials.gov36/100

Astaxanthin for Management of Inflammation in Knee Osteoarthritis

ClinicalTrials.gov study NCT05138549. IPD Sharing: NO. Countries: 1. Publications: 8.

closedIPD-NOFeb 2026View details →
dryad36/100

Data from: Optimization and characterization of PLGA nanoparticles loaded with Astaxanthin and evaluation of anti-photodamage effect in vitro

Open the record for dataset details and reuse information.

publicOct 2019View details →
dryad36/100

Astaxanthin from Haematococcus pluvialis prevents high-fat diet-induced hepatic steatosis and oxidative stress in mice by gut-liver axis modulating properties

Open the record for dataset details and reuse information.

publicApr 2022View details →
ClinicalTrials.gov32/100

Astaxanthin Effects on Osteoarthritis Associated Pain and Inflammatory Indicators

ClinicalTrials.gov study NCT03664466. IPD Sharing: NO. Countries: 1. Publications: 49.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Effects of Astaxanthin Supplementation

ClinicalTrials.gov study NCT06511960. IPD Sharing: NO. Countries: 1. Publications: 14.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Study of the Efficacy and Safety of Antioxidants Astaxanthin as an Adjuvant Therapy for Community Acquired Pneumonia Patients.

ClinicalTrials.gov study NCT06334874. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Oral Astaxanthin and Semen Quality, Fertilization and Embryo Development in Assisted Reproduction Techniques Procedures

ClinicalTrials.gov study NCT02310087. IPD Sharing: NO. Countries: 1. Publications: 9.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Effect of Astaxanthin Supplementation on Plasma Malondialdehyde Levels and NIHSS of Stroke Patients

ClinicalTrials.gov study NCT03945526. IPD Sharing: NO. Countries: 1. Publications: 6.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Evaluation of Astaxanthin Properties on Anti-fatigue

ClinicalTrials.gov study NCT06593535. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

The Effectiveness of Astaxanthin Supplementation on the Clinical Symptoms and Cardio-metabolic Profile in Women with Polycystic Ovary Syndrome

ClinicalTrials.gov study NCT06642363. IPD Sharing: NO. Countries: 1. Publications: 20.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

The Benefits of Astaxanthin as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient

ClinicalTrials.gov study NCT04689984. IPD Sharing: NO. Countries: 1. Publications: 9.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation

ClinicalTrials.gov study NCT07063056. IPD Sharing: NO. Countries: 1. Publications: 4.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

The Effect of Astaxanthin on Oxidative Stress Indices in Patients With Polycystic Ovary Syndrome

ClinicalTrials.gov study NCT03991286. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Astaxanthin Supplementation in Cyclists

ClinicalTrials.gov study NCT01241877. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Astaxanthin Formulation Bioavailability

ClinicalTrials.gov study NCT02397811. IPD Sharing: Not stated. Countries: 1. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Impact of Astaxanthin on Cognition in Recreationally Active Females

ClinicalTrials.gov study NCT06460181. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Evaluating Astaxanthin Bioavailability, and a New Technology for Improving it, Using Natural Food Materials Only

ClinicalTrials.gov study NCT04583722. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record